Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Venous Thromboembolism in the Hematologic Malignancies
Journal of Clinical Oncology, 09/21/09
Falanga A et al. – Patients with hematologic malignancies are at high risk of thrombotic or hemorrhagic complications. The incidence of these events is greatly variable and is influenced by many factors, including the type of disease, the type of chemotherapy, and the use of central venous device (CVD). No recommendation for routine thromboprophylaxis in these conditions, with the exception of MM, is available. Large, prospective, randomized clinical trials are needed to establish the best practice for thromboprophylaxis and treatment of VTE in these types of cancers.
Related Articles
Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
Chest, 10/08/09
Relevance Score: 83%
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials
Circulation, 11/04/09
Relevance Score: 82%
Hematocrit and risk of venous thromboembolism in a general population. The Tromso Study
Haematologica, 10/21/09
Relevance Score: 82%
2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group
Critical Reviews in Oncology/Hematology, 10/07/09
Relevance Score: 82%
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
Annals of Oncology, 10/20/09
Relevance Score: 81%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
Transfusion, 12/16/09
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis
Transfusion, 12/16/09
An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B
Haemophilia, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


